Clarifying the categorization of anaphylaxis as an adverse event during oral immunotherapy. (2022)

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.jaci.2022.02.032

PubMed Identifier: 35491265

Publication URI: http://europepmc.org/abstract/MED/35491265

Type: Journal Article/Review

Volume: 150

Parent Publication: The Journal of allergy and clinical immunology

Issue: 1

ISSN: 0091-6749